US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.20

-0.2200-2.11%

Volume:124.17K

Turnover:1.28M

Market Cap:498.63M

PE:-3.18

High:10.61

Open:10.49

Low:10.10

Close:10.42

52wk High:14.53

52wk Low:2.22

Shares:48.89M

Float Shares:19.28M

Volume Ratio:0.59

T/O Rate:0.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2084

EPS(LYR):-3.4309

ROE:-36.58%

ROA:-22.34%

PB:1.43

PE(LYR):-2.97

Loading ...

Overview Company News Filings

Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725

Artiva Biotherapeutics Launches Phase 3 Trial of AlloNK Plus Rituximab in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics Provides Update on Planned Allonk® Data Disclosures and Development Milestones for the Remainder of 2026

THOMSON REUTERS

Artiva Biotherapeutics - to Disclose Updated Phase 2a Ra Data from at Least 20 Patients in H2 2026

THOMSON REUTERS

Artiva Biotherapeutics - Expects Phase 3 Ra Trial Topline Results by End of 2028

THOMSON REUTERS

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Top Artiva Biotherapeutics Executives Quietly Unload a Wave of Shares

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September

Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32

Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan

Artiva Biotherapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Artiva Biotherapeutics files $400M mixed securities shelf

Artiva Biotherapeutics - May Offer up to $400 Mln in Securities - SEC Filing

THOMSON REUTERS

Artiva Biotherapeutics Q2 FY26 Net Loss Widens to $25.01 Million; R&D Expenses Rise to $21.93 Million

Artiva Biotherapeutics Inc: Qtrly EPS $-0.63

THOMSON REUTERS

Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Artiva Biotherapeutics Announces Annual Shareholder Meeting

Major Investment Move Signals Growing Confidence in Artiva Biotherapeutics

RA Capital Management Buys USD 456,297 of Artiva Biotherapeutics Common Shares

Artiva Biotherapeutics Inc Expected to Post a Loss of 62 Cents a Share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/ARTV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":10.2,"timestamp":1789149532198,"preClose":10.42,"halted":0,"volume":124169,"delay":0,"changeRate":-0.021113243761996223,"floatShares":19275997,"shares":48885777,"eps":-3.20842,"marketStatus":"Trading","change":-0.22,"latestTime":"09-11 13:59:01 EDT","open":10.49,"high":10.61,"low":10.1,"amount":1277024.896499,"amplitude":0.048944,"askPrice":10.21,"askSize":275,"bidPrice":10.16,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-3.20842,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":10.42,"preHourTrading":{"tag":"盘前","latestPrice":10.47,"preClose":10.42,"latestTime":"09:29 EDT","volume":58,"amount":607.47257,"timestamp":1789133341101,"change":0.05,"changeRate":0.004798,"amplitude":0.020393},"postHourTrading":{"tag":"盘后","latestPrice":10.46,"preClose":10.42,"latestTime":"19:37 EDT","volume":8216,"amount":85631.86,"timestamp":1789083440066,"change":0.04,"changeRate":0.003839,"amplitude":0.003839},"volumeRatio":0.589702,"impliedVol":0.8544,"impliedVolPercentile":0.4865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":19275997,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":0.589702,"shares":48885777,"dividePrice":0,"high":10.61,"amplitude":0.048944,"preClose":10.42,"low":10.1,"week52Low":2.22,"pbRate":"1.43","week52High":14.53,"institutionHeld":0,"latestPrice":10.2,"committee":-0.641791,"eps":-3.20842,"divideRate":0,"volume":124169,"delay":0,"ttmEps":-3.20842,"open":10.49,"prevYearClose":4.29,"prevWeekClose":11.19,"prevMonthClose":11.3,"prevQuarterClose":9.7,"fiveDayClose":11.125,"twentyDayClose":11.3,"sixtyDayClose":8.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-09-10","current":-3.247704,"percent":0.188571,"low":-11.820615,"twenty":-5.58036,"median":-1.764919,"eighty":-0.949306,"high":-0.499349,"avg":-3.306672,"sd":2.97255,"marketCap":527524405},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947},{"date":"2026-08-28","current":-6.427457,"twenty":-5.453128,"median":-1.724769,"eighty":-0.944323,"marketCap":583748044},{"date":"2026-09-04","current":-5.988732,"twenty":-5.513396,"median":-1.759981,"eighty":-0.947685,"marketCap":543902596},{"date":"2026-09-10","current":-5.808397,"twenty":-5.58036,"median":-1.764919,"eighty":-0.949306,"marketCap":527524405}],"updateTime":1789122259287},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666753717","title":"Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725","url":"https://stock-news.laohu8.com/highlight/detail?id=2666753717","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666753717?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:03","pubTimestamp":1788984210,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CEO Fred Aslan disposes of 23,429 common shares worth $255,725Artiva Biotherapeutics CEO Fred Aslan sold 23,429 shares of common stock on Sept. 8, 2026.Weighted average sale pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6YDH3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics CEO Fred Aslan Disposes of 23,429 Common Shares Worth $255,725","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327936","title":"Artiva Biotherapeutics Launches Phase 3 Trial of AlloNK Plus Rituximab in Refractory Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327936","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327936?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:32","pubTimestamp":1788867146,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics launches Phase 3 trial of AlloNK plus rituximab in refractory rheumatoid arthritisArtiva outlined second-half 2026 data disclosures for AlloNK with rituximab in its Phase 2a aut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1brkJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","SG9999014021.USD","IE00BQXX3D17.EUR","LU0314104364.USD","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4139","SG9999014013.SGD","IE00BQXX3F31.USD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","ARTV","SG9999014039.USD","BCDF","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327687","title":"Artiva Biotherapeutics Provides Update on Planned Allonk® Data Disclosures and Development Milestones for the Remainder of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327687?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327572","title":"Artiva Biotherapeutics - to Disclose Updated Phase 2a Ra Data from at Least 20 Patients in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327572?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665275073","title":"Artiva Biotherapeutics - Expects Phase 3 Ra Trial Topline Results by End of 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2665275073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665275073?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4TYRM1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378124","title":"Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378124","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378124?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:30","pubTimestamp":1788867000,"startTime":"0","endTime":"0","summary":"Updated clinical data expected in the second half of 2026 from at least 20 patients with refractory rheumatoid arthritis (RA) treated with AlloNK and rituximab in the ongoing company-sponsored Phase 2","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357530/0/en/artiva-biotherapeutics-provides-update-on-planned-allonk-data-disclosures-and-development-milestones-for-the-remainder-of-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV","RA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665357770","title":"Top Artiva Biotherapeutics Executives Quietly Unload a Wave of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665357770","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665357770?lang=en_us&edition=fundamental","pubTime":"2026-09-05 10:06","pubTimestamp":1788574013,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on September 4, 2026. Artiva Biotherapeutics, Inc. has seen signif...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-artiva-biotherapeutics-executives-quietly-unload-a-wave-of-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-artiva-biotherapeutics-executives-quietly-unload-a-wave-of-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811265","title":"Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811265","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811265?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept.  02, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355154/0/en/artiva-biotherapeutics-to-participate-in-upcoming-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RA","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869118","title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869118","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869118?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:07","pubTimestamp":1788217640,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32Artiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 8,222 common shares on Aug. 27 at USD 12.01.He","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLb5ByDm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 8,222 Shares for $98,730.32","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660749764","title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660749764","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660749764?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:01","pubTimestamp":1787187675,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 429 common shares worth $5,148 under 10b5-1 planArtiva Biotherapeutics Chief Medical Officer Subhashis Banerjee sold 429 common shares on Aug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL2KsMjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Artiva Biotherapeutics CMO Subhashis Banerjee Disposes of 429 Common Shares Worth $5,148 Under 10b5-1 Plan","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266428","title":"Artiva Biotherapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266428","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266428?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:12","pubTimestamp":1786061565,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryArtiva Biotherapeutics IncARTV.OQreported a quarterly adjusted loss of 63 cents per share for the quarter end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N44400A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666627","title":"Artiva Biotherapeutics files $400M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666627?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:30","pubTimestamp":1786051859,"startTime":"0","endTime":"0","summary":"17:27 EDT Artiva Biotherapeutics (ARTV) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-mo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-files-400m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-files-400m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665272","title":"Artiva Biotherapeutics - May Offer up to $400 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665272?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:21","pubTimestamp":1786051293,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN443248:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650799","title":"Artiva Biotherapeutics Q2 FY26 Net Loss Widens to $25.01 Million; R&D Expenses Rise to $21.93 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650799","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650799?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:23","pubTimestamp":1786047831,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Q2 FY26 net loss widens to $25.01 million; R&D expenses rise to $21.93 millionArtiva Biotherapeutics posted a Q2 net loss of USD 25.01 million, widening from USD 21.25 million a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3tMfW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2V16.EUR","LU2210150020.SGD","ARTV","IE00BN0W2W23.USD","SG9999014013.SGD","BK4139","BK4112","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","BCDF","LU0314104364.USD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665093","title":"Artiva Biotherapeutics Inc: Qtrly EPS $-0.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665093","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665093?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046711,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUAZZ6S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661123","title":"Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661123","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661123?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"Clinical, safety and translational data presented at EULAR 2026 reinforced AlloNK’s potential to drive deep B-cell depletion and meaningful clinical activity, with a tolerability profile supportive of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340735/0/en/Artiva-Biotherapeutics-Reports-Second-Quarter-2026-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYZ","BK4187","BK4139","CRS","IE00B66KJ199.SGD","RA","IE00B7SZL793.SGD","LU2065731478.USD","ARTV","BK4006","IE0031619046.USD","LU0963586101.USD","XAR","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656301950","title":"Artiva Biotherapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301950","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301950?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:09","pubTimestamp":1785787770,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics announces annual shareholder meetingArtiva Biotherapeutics will hold its annual stockholders meeting virtually on Sept. 8, 2026.Shareholders will vote to elect two Class II dire","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLNb4gC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656397769","title":"Major Investment Move Signals Growing Confidence in Artiva Biotherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2656397769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656397769?lang=en_us&edition=fundamental","pubTime":"2026-08-01 10:05","pubTimestamp":1785549937,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on July 31, 2026. Director Ra Capital Management, LLC has made a n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investment-move-signals-growing-confidence-in-artiva-biotherapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investment-move-signals-growing-confidence-in-artiva-biotherapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391764","title":"RA Capital Management Buys USD 456,297 of Artiva Biotherapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391764","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391764?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:13","pubTimestamp":1785532425,"startTime":"0","endTime":"0","summary":"RA Capital Management buys USD 456,297 of Artiva Biotherapeutics common sharesRA Capital Management reported open-market purchases of Artiva Biotherapeutics common stock at USD 9.93–9.99 a share.Benef","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL8kHhwP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management Buys USD 456,297 of Artiva Biotherapeutics Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655157368","title":"Artiva Biotherapeutics Inc Expected to Post a Loss of 62 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655157368","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655157368?lang=en_us&edition=fundamental","pubTime":"2026-07-31 19:04","pubTimestamp":1785495845,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc <ARTV.OQ> expected to post a loss of62cents a share - Earnings PreviewArtiva Biotherapeutics IncARTV.OQARTV.Ois expected to  show no change in quarterly revenue when it repo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X1F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":89,"code":"91000000","status":"200"}]}}